Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Nov
2
2014
Ghana Achieves “Zero Hunger” Covington & Burling LLP
Oct
31
2014
FDA and the Center for Food Safety Reach Settlement Regarding FDA’s GRAS Rule Mintz
Oct
30
2014
Ariosa Diagnostics v. Verinata Health, Inc.: Final Written Decision IPR2014-00276 Faegre Drinker
Oct
30
2014
Biometric Screening Requirement Under Wellness Program Violates ADA and GINA, According to EEOC Suit Jackson Lewis P.C.
Oct
30
2014
Medical Device Update: Distinguishing Medical Device Recalls from Medical Device Enhancements Morgan, Lewis & Bockius LLP
Oct
29
2014
Marijuana Users in Michigan Eligible for Unemployment Proskauer Rose LLP
Oct
29
2014
Progress Update: House Energy and Commerce Committee (E&C) 21st Century Cures Initiative McDermott Will & Emery
Oct
29
2014
Ebola Exclusions from Commercial Insurance Policies Mintz
Oct
29
2014
U.S. Immigration Policy Catches Up with Assisted Reproductive Technology Mintz
Oct
29
2014
Recent Trends in Medical Device Patent Litigation at the ITC — Part 1 Covington & Burling LLP
Oct
29
2014
Government Looking to Existing Procurement Vehicles to Stem Ebola Threat Covington & Burling LLP
Oct
28
2014
Texas Federal Jury Sides with J&J’s DePuy In First Pinnacle Hip Implant Trial Covington & Burling LLP
Oct
28
2014
CMS Releases Preliminary 2015 Clinical Laboratory Fee Schedule Rates McDermott Will & Emery
Oct
28
2014
Bostwick Laboratories Agrees to Pay U.S. Government $6.05 Million for Allegedly Violating the Anti-Kickback Statue; Whistleblower to Receive Reward Tycko & Zavareei LLP
Oct
28
2014
Michigan Medical Marijuana Law Allows Employees Terminated for Positive Marijuana Test Results to Receive Unemployment Benefits Jackson Lewis P.C.
Oct
27
2014
A Review of the Status of Biosimilars in the U.S. Michael Best & Friedrich LLP
Oct
25
2014
EPA Updates Toxic Substances Control Act (TSCA) Work Plan for Chemical Assessments Beveridge & Diamond PC
Oct
24
2014
FTC Takes Action Against Unsubstantiated Caffeine-Infused Shapewear Weight-Loss Claims Sheppard, Mullin, Richter & Hampton LLP
Oct
23
2014
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 23, 2014 Mintz
Oct
23
2014
Uncertain Times for Biotech and Pharma Patents Vedder Price
Oct
23
2014
California Battle of the Experts Still Brewin’ in Starbucks Trial Mintz
Oct
22
2014
Mushroom Growers Denied Capper-Volstead Antitrust Immunity McDermott Will & Emery
Oct
22
2014
California Court Has a Bone to Pick with Male Enhancement Pill Maker Proskauer Rose LLP
Oct
21
2014
Ebola Spurs Global Cooperation to Prevent, Detect and Respond to Future Health Crises Covington & Burling LLP
Oct
21
2014
Health Care Researchers Publish on the Implications of New Provider Payment Models on Innovative Medical Technology Analysis Group, Inc.
Oct
21
2014
Biotechnology Industry Organization (BIO) Provides Supplemental Comments on PTO s.101 Guidelines Schwegman, Lundberg & Woessner, P.A.
Oct
21
2014
FDA Issues Final Guidance on Distinguishing Medical Device Recall from Product Enhancement Barnes & Thornburg LLP
Oct
20
2014
Time is of the Essence: Review Your Workplace Policies Before Medical Marijuana is Available in IL Heyl, Royster, Voelker & Allen, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins